Tag: nuclear medicine

Nadine Mallak MD 3

Dr. Nadine Mallak to Be Featured Guest for CCF’s Luncheon with the Experts

March 19, 2022

Nadine Mallak, MD, will be the featured guest for CCF’s Facebook Live Luncheon with the Experts on Thursday, March 24, 2022 from 12 noon to 1 pm, Eastern Time. A nuclear medicine and body radiologist, Dr. Mallak is Assistant Professor of Diagnostic Radiology,…

READ MORE
Sugandha Dureja MD FEBNM Aug12

Dr. Sugandha Dureja to be Featured Guest for CCF’s Luncheon with the Experts

August 8, 2021

Sugandha Dureja, MD, FEBNM, nuclear medicine specialist, will be the featured guest for Facebook Live Luncheon with the Experts on Thursday, August 12, 2021 from 12 noon to 1 pm, Eastern Time.

Dr. Dureja is among the first Indian specialists with international…

READ MORE
josh mailman 5

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging 2014 Meeting

April 25, 2014

Josh Mailman, President of the NorCal CarciNET Community  and Chair of the Patient Advocacy Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June…

READ MORE
Multidisciplinary Team at Bad Berka

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

April 5, 2011

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …

READ MORE
ebrahim s delpassand md facnm

FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)

August 24, 2010

For the first time in North America, neuroendocrine cancer patients will have the opportunity to participate in a clinical trial of Lutetieum-177 (LU-177)with Octreotate. Ebrahim S. Delpassand, MD, chief executive officer and medical director of…

READ MORE
y 90 radiomicrosphere therapy workshop banner2

Y-90 Radiomicrosphere Therapy Workshop To Be Offered in Florida

May 12, 2010

Carcinoid and neuroendocrine cancer patients interested in learning more about Y-90 radiomicrosphere therapy can join physicians, scientists, and technologists for a workshop being presented by “Advances in Minimally Invasive Treatments” International

READ MORE